{"id":8019,"date":"2026-09-09T06:35:49","date_gmt":"2026-09-09T13:35:49","guid":{"rendered":"https:\/\/rakuten-med.com\/us\/?post_type=press_releases&#038;p=8019"},"modified":"2026-09-09T16:38:47","modified_gmt":"2026-09-09T23:38:47","slug":"rakuten-medical-appoints-christophe-weber-as-vice-chairman-and-ken-takeshita-m-d-as-director-to-accelerate-u-s-growth-and-oncology-innovation","status":"publish","type":"press_releases","link":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/","title":{"rendered":"Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation"},"content":{"rendered":"<div id=\"pl-8019\"  class=\"panel-layout\" ><div id=\"pg-8019-0\"  class=\"panel-grid panel-no-style\"  style=\"margin-bottom: 0px\" ><div id=\"pgc-8019-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-8019-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<ul>\n<li><b><i>Enhanced Board and leadership team, including the appointment of a new Chief Medical Officer, strengthens governance, execution and clinical capabilities<\/i><\/b><\/li>\n<\/ul>\n<p><b>SAN DIEGO \u2014 September 9, 2026 \u2014 <\/b><span style=\"font-weight: 400\">Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox\u00ae platform-based photoimmunotherapy, today announced the appointment of Christophe Weber as Vice Chairman of the Board of Directors and Ken Takeshita, M.D. as a Director, effective September 1, 2026. The company also appointed Hassan Danesi, M.D., MBA, as Chief Medical Officer (CMO). These appointments strengthen Rakuten Medical\u2019s governance, execution and clinical expertise while enhancing the capabilities needed to advance regulatory and commercial milestones in the United States and expand its development programs.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Rakuten Medical is pursuing regulatory approvals in the United States and other markets for pharmaceutical and medical device components of its proprietary Alluminox platform-based photoimmunotherapy for the treatment of head and neck cancer. The company is also advancing research and development programs to evaluate the platform\u2019s potential across additional cancer indications.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Minami Maeda, Chief Executive Officer of Rakuten Medical, commented, \u201cRakuten Medical is entering an important phase of growth. Positioning our company to deliver this first-of-its-kind approach to cancer care to patients worldwide requires strong execution, deep oncology expertise and proven global leadership. We are pleased to welcome Christophe and Ken to our Board, bringing exceptional experience in global business leadership and oncology research and development. Our strengthened Board and leadership team position Rakuten Medical to execute on our strategic priorities and accelerate our next phase of growth.\u201d<\/span><\/p>\n<p><i><span style=\"font-weight: 400\">Disclaimer: Rakuten Medical\u2019s Alluminox\u00ae platform-based photoimmunotherapy is investigational outside Japan.<\/span><\/i><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-8019-1\"  class=\"panel-grid panel-no-style\"  style=\"margin-bottom: 0px\" ><div id=\"pgc-8019-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-8019-1-0-0\" class=\"so-panel widget widget_sow-image panel-first-child panel-last-child\" data-index=\"1\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-image so-widget-sow-image-default-113ccd71f3e6-8019\"\n\t\t\t\n\t\t>\n<div class=\"sow-image-container\">\n\t\t<img \n\tsrc=\"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-Weber-1.jpg\" width=\"966\" height=\"1120\" srcset=\"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-Weber-1.jpg 966w, https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-Weber-1-259x300.jpg 259w, https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-Weber-1-883x1024.jpg 883w, https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-Weber-1-768x890.jpg 768w\" sizes=\"(max-width: 966px) 100vw, 966px\" title=\"Christophe Weber,  Vice Chairman of the Board\" alt=\"\" \t\tclass=\"so-widget-image\"\/>\n\t<\/div>\n\n<h3 class=\"widget-title\">Christophe Weber,  Vice Chairman of the Board<\/h3><\/div><\/div><\/div><div id=\"pgc-8019-1-1\"  class=\"panel-grid-cell\" ><div id=\"panel-8019-1-1-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"2\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><span style=\"font-weight: 400\">Christophe Weber, Vice Chairman of the Board, commented, \u201cRakuten Medical is guided by a clear mission to conquer cancer and is advancing innovative therapies that integrate pharmaceuticals and medical devices. Throughout my career, I have focused on bringing transformative therapies to patients around the world through global business leadership and organizational transformation. I look forward to supporting Rakuten Medical as it expands its global reach and delivers new value to patients worldwide.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">Weber served as President and Chief Executive Officer of Takeda Pharmaceutical Company Limited from 2015 to 2026, leading the company\u2019s transformation into one of the world\u2019s top pharmaceutical organizations. During his tenure, he strengthened Takeda\u2019s global operating model through business transformation initiatives, portfolio optimization, and strategic acquisitions. Prior to joining Takeda, he spent more than 20 years at GlaxoSmithKline (GSK), where he held senior leadership positions across Europe, the United States, and Asia, including President and CEO of GSK France, Regional Head of Asia Pacific, and President and General Manager of GSK Vaccines. Most recently, he joined the Board of Directors of Boston Scientific Corporation, a global medical technology company, in February 2026.<\/span><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-8019-2\"  class=\"panel-grid panel-no-style\"  style=\"margin-bottom: 0px\" ><div id=\"pgc-8019-2-0\"  class=\"panel-grid-cell\" ><div id=\"panel-8019-2-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"3\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><span style=\"font-weight: 400\">Ken Takeshita, Director, commented, \u201cThe Alluminox platform is built on highly transformative science with the potential to create new treatment possibilities for cancer patients. My experience spans the full continuum of oncology innovation, from academic research and translational science to global clinical development. I am excited to support the continued advancement of Rakuten Medical\u2019s scientific foundation and help expand its potential across a broader range of cancers.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">Takeshita is a physician and global leader in oncology research and clinical development. Most recently, he served as Global Head of Research &amp; Development at Daiichi Sankyo, where he oversaw the company\u2019s pipeline strategy, including its antibody-drug conjugate (ADC) portfolio. Previously, he held senior leadership positions at Amgen, Celgene and Kite Pharma, leading development programs across both hematologic malignancies and solid tumors, and contributing to the advancement of novel modalities, including cell therapies. Prior to joining the biopharmaceutical industry, Takeshita served on the faculties of Yale University School of Medicine and New York University School of Medicine.<\/span><\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-8019-2-1\"  class=\"panel-grid-cell\" ><div id=\"panel-8019-2-1-0\" class=\"so-panel widget widget_sow-image panel-first-child panel-last-child\" data-index=\"4\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-image so-widget-sow-image-default-113ccd71f3e6-8019\"\n\t\t\t\n\t\t>\n<div class=\"sow-image-container\">\n\t\t<img \n\tsrc=\"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Ken_Takeshita.jpg\" width=\"623\" height=\"722\" srcset=\"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Ken_Takeshita.jpg 623w, https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Ken_Takeshita-259x300.jpg 259w\" sizes=\"(max-width: 623px) 100vw, 623px\" title=\"Ken Takeshita, M.D., Director\" alt=\"\" \t\tclass=\"so-widget-image\"\/>\n\t<\/div>\n\n<h3 class=\"widget-title\">Ken Takeshita, M.D., Director<\/h3><\/div><\/div><\/div><\/div><div id=\"pg-8019-3\"  class=\"panel-grid panel-no-style\"  style=\"margin-bottom: 0px\" ><div id=\"pgc-8019-3-0\"  class=\"panel-grid-cell\" ><div id=\"panel-8019-3-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"5\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><span style=\"font-weight: 400\">\u201cAt Rakuten Medical, we remain committed to our mission,\u201d said Mickey Mikitani, Executive Chairman of the Board of Rakuten Medical. \u201cChristophe\u2019s extensive experience in global business leadership and Ken\u2019s deep expertise in oncology R&amp;D will be invaluable as we continue to build the company for long-term success. Together with our strengthened leadership team, we will further enhance our business and scientific capabilities to bring meaningful new value to patients worldwide.\u201d<\/span><\/p>\n<p>A complete list of Rakuten Medical's current Board of Directors and Leadership Team is available on our <a href=\"https:\/\/rakuten-med.com\/us\/about\/leadership\/\">Leadership page<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-8019-4\"  class=\"panel-grid panel-no-style\"  style=\"margin-bottom: 0px\" ><div id=\"pgc-8019-4-0\"  class=\"panel-grid-cell\" ><div id=\"panel-8019-4-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"6\" ><div class=\"panel-widget-style panel-widget-style-for-8019-4-0-0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><b>About Alluminox\u00ae platform<br \/>\n<\/b><span style=\"font-weight: 400\">The Alluminox platform is Rakuten Medical\u2019s investigational technology platform that combines pharmaceuticals, medical devices, medical technology, and other peripheral technologies. Rakuten Medical is developing Alluminox platform-based photoimmunotherapy, which involves two key steps: 1) drug administration and 2) targeted illumination using medical devices. The drug component consists of a cell-targeting moiety conjugated to a light-activatable dye, such as IRDye\u00ae 700DX (IR700), that selectively binds to the surface of targeted cells, such as tumor cells. The device component consists of a light source that locally illuminates the targeted cells with red light (690nm) to transiently activate the drug. Rakuten Medical\u2019s pre-clinical data have shown that this activation elicits rapid and selective necrosis of targeted cells through a biophysical process that compromises the membrane integrity of the targeted cells. Therapies developed on the Alluminox platform may also result in local and systemic innate and adaptive immune activation due to immunogenic cell death of the targeted tumor cells and\/or the removal of targeted immunosuppressive cells within the tumor microenvironment. Photoimmunotherapy was originally developed by Dr. Hisataka Kobayashi and his team at the National Cancer Institute in the United States. Outside Japan, Rakuten Medical\u2019s Alluminox platform-based photoimmunotherapy is investigational.\u00a0<\/span><\/p>\n<p><b>About Rakuten Medical, Inc.<br \/>\n<\/b>Rakuten Medical, Inc. is a global biotechnology company developing and commercializing Alluminox\u00ae platform-based photoimmunotherapy, which, in pre-clinical studies, has been shown to induce rapid and selective cell killing. Rakuten Medical\u2019s photoimmunotherapy is currently investigational outside Japan. Rakuten Medical is committed to its mission to conquer cancer by developing its pioneering treatments as quickly as possible to as many patients as possible all over the world. The company has offices in 5 countries\/regions, including the United States, where it is headquartered, Japan, Taiwan, Switzerland and India. For more information, visit our <a href=\"http:\/\/www.rakuten-med.com\/\">website<\/a>, <a href=\"https:\/\/www.linkedin.com\/company\/rakuten-medical\" target=\"_blank\" rel=\"noopener\">LinkedIn<\/a> and <a href=\"https:\/\/www.youtube.com\/@rakutenmedical7070\" target=\"_blank\" rel=\"noopener\">YouTube<\/a>.<\/p>\n<p><b><br \/>\nInvestor Contact:<br \/>\n<\/b><span style=\"font-weight: 400\">Abhijit Bhatia<br \/>\n<\/span><span style=\"font-weight: 400\">Chief Operating Officer<br \/>\n<\/span>Tel: +1-619-650-1549<br \/>\n<span style=\"font-weight: 400\">Email: <\/span><a href=\"mailto:abhijit.bhatia@rakuten-med.com\"><span style=\"font-weight: 400\">abhijit.bhatia@rakuten-med.com<\/span><\/a><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><span style=\"font-weight: 400\">Ai Yoshikawa<br \/>\n<\/span><span style=\"font-weight: 400\">Associate Director, Global Corporate Communications<br \/>\n<\/span><span style=\"font-weight: 400\">Tel: +81-(0)70-4196-0845<br \/>\n<\/span><span style=\"font-weight: 400\">Email: <\/span><a href=\"mailto:ai.yoshikawa@rakuten-med.com\"><span style=\"font-weight: 400\">ai.yoshikawa@rakuten-med.com<\/span><\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div><div id=\"pg-8019-5\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-8019-5-0\"  class=\"panel-grid-cell\" ><div id=\"panel-8019-5-0-0\" class=\"so-panel widget widget_sow-button panel-first-child panel-last-child\" data-index=\"7\" ><div style=\"padding: 30px 0px 0px 0px;\" class=\"panel-widget-style panel-widget-style-for-8019-5-0-0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-button so-widget-sow-button-flat-6fd36f18507f-8019\"\n\t\t\t\n\t\t><div class=\"ow-button-base ow-button-align-center\"\n>\n\t\t\t<a\n\t\t\t\t\thref=\"https:\/\/rakuten-med.com\/us\/contact\/\"\n\t\t\t\t\tclass=\"rakuten-btn sowb-button ow-icon-placement-left ow-button-hover\" \t>\n\t\t<span>\n\t\t\t\n\t\t\tContact Us\t\t<\/span>\n\t\t\t<\/a>\n\t<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Enhanced Board and leadership team, including the appointment of a new Chief Medical Officer, strengthens governance, execution and clinical capabilities [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":8023,"template":"","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"class_list":["post-8019","press_releases","type-press_releases","status-publish","has-post-thumbnail","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation - Rakuten Medical - To conquer cancer.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation - Rakuten Medical - To conquer cancer.\" \/>\n<meta property=\"og:description\" content=\"Enhanced Board and leadership team, including the appointment of a new Chief Medical Officer, strengthens governance, execution and clinical capabilities [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/\" \/>\n<meta property=\"og:site_name\" content=\"Rakuten Medical - To conquer cancer.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-09T23:38:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-and-Ken.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2026\\\/09\\\/09\\\/8019\\\/\",\"url\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2026\\\/09\\\/09\\\/8019\\\/\",\"name\":\"Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation - Rakuten Medical - To conquer cancer.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2026\\\/09\\\/09\\\/8019\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2026\\\/09\\\/09\\\/8019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2026\\\/09\\\/Christophe-and-Ken.png\",\"datePublished\":\"2026-09-09T13:35:49+00:00\",\"dateModified\":\"2026-09-09T23:38:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2026\\\/09\\\/09\\\/8019\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2026\\\/09\\\/09\\\/8019\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2026\\\/09\\\/09\\\/8019\\\/#primaryimage\",\"url\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2026\\\/09\\\/Christophe-and-Ken.png\",\"contentUrl\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2026\\\/09\\\/Christophe-and-Ken.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2026\\\/09\\\/09\\\/8019\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/\",\"name\":\"Rakuten Medical - To conquer cancer.\",\"description\":\"Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox\u2122TM technology platform. We are committed to our mission to conquer cancer and aim to achieve a society where cancer patients can lead fulfilling lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation - Rakuten Medical - To conquer cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/","og_locale":"en_US","og_type":"article","og_title":"Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation - Rakuten Medical - To conquer cancer.","og_description":"Enhanced Board and leadership team, including the appointment of a new Chief Medical Officer, strengthens governance, execution and clinical capabilities [&hellip;]","og_url":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/","og_site_name":"Rakuten Medical - To conquer cancer.","article_modified_time":"2026-09-09T23:38:47+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-and-Ken.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/","url":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/","name":"Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation - Rakuten Medical - To conquer cancer.","isPartOf":{"@id":"https:\/\/rakuten-med.com\/us\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/#primaryimage"},"image":{"@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/#primaryimage"},"thumbnailUrl":"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-and-Ken.png","datePublished":"2026-09-09T13:35:49+00:00","dateModified":"2026-09-09T23:38:47+00:00","breadcrumb":{"@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/#primaryimage","url":"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-and-Ken.png","contentUrl":"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2026\/09\/Christophe-and-Ken.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2026\/09\/09\/8019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rakuten-med.com\/us\/"},{"@type":"ListItem","position":2,"name":"Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation"}]},{"@type":"WebSite","@id":"https:\/\/rakuten-med.com\/us\/#website","url":"https:\/\/rakuten-med.com\/us\/","name":"Rakuten Medical - To conquer cancer.","description":"Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox\u2122TM technology platform. We are committed to our mission to conquer cancer and aim to achieve a society where cancer patients can lead fulfilling lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rakuten-med.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/press_releases\/8019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/types\/press_releases"}],"author":[{"embeddable":true,"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/users\/4"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/media\/8023"}],"wp:attachment":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/media?parent=8019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}